EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in Nigeria

Olusegun A Adeyemi iD, Rebecca G Nowak, Mark Marzinke, Daniel Morgan, Nadia Sam-Agudu, Jaih Craddock iD, Min Zhan, Trevor A Crowell iD, Stefan Baral, Nicaise Ndembi, Sylvia Adebajo, Manhattan E Charurat und 1 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0282999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Olusegun A Adeyemi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Epidemiology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America. Hauptthemen laut MEDLINE: HIV Infections, Pre-Exposure Prophylaxis, Anti-HIV Agents, Sexual and Gender Minorities. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CDC HHS, NIMH NIH HHS, FIC NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

HIV pre-exposure prophylaxis (PrEP) significantly reduces the risk of HIV acquisition. However, studies have demonstrated discordance between self-reported measures and biomedical benchmarks of PrEP adherence. We estimated the correlation between self-reported PrEP adherence and PrEP biomarkers and explored factors associated with adherence among men who have sex with men (MSM) in Nigeria.

Methods

TRUST-PrEP, an open-label, prospective study; conducted in Abuja between April 2018 and May 2019. MSM ≥ 18 years with substantial HIV risk were enrolled. Participants reported PrEP adherence in the last month using a 4-point scale from “poor” to “perfect” and serum samples for PrEP biomarkers were collected at months 3 and 9. Serum tenofovir concentration was measured by liquid chromatography-tandem mass spectrometry and considered protective for adherence if ≥ 4.2 ng/ml. Spearman’s rank correlation was used to estimate correlation between self-reported adherence and measured tenofovir levels. Generalized estimating equations with a logit link was used to estimate adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for associations between self-reported adherence and laboratory-measured adherence.

Results

A total of 219 MSM with median age 23 (interquartile range 20–27) years had at least one PrEP biomarker assay. Only 66/219 (30%) had at least one record of protective tenofovir concentration. Correlation between tenofovir and self-reported adherence at 3 and 9 months were 0.1 and 0.02 respectively. Furthermore, 17/219 (8%,) and 49/219 (22%) had serum tenofovir of 4.2–35.4 ng/mL and ≥ 35.5 ng/mL, corresponding to at least 4 and 7 days’ PrEP use in a week, respectively. PrEP adherence was higher among participants introduced to PrEP in the clinics compared with communities (aOR: 8.35, 95%CI: [3.24, 21.5]) and those with same-sex practices family disclosure (aOR: 3.60 95% CI: [1.73, 7.51]).

Conclusion

Self-reported PrEP adherence poorly correlated with biomarkers. Facilitating clinic-based PrEP introduction and disclosure of same-sex practices to family among MSM may improve PrEP adherence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPre-Exposure ProphylaxisAnti-HIV AgentsSexual and Gender MinoritiesMaleHumansYoung AdultAdultFemaleHomosexuality, MaleSelf ReportProspective StudiesNigeriaTenofovirBiomarkersMedication Adherence

Substanzen

Anti-HIV AgentsTenofovirBiomarkers

Autor:innen und Institutionen

  • Department of Public Health and Epidemiology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
  • International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
  • Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • School of Social Work, University of Maryland, Baltimore, MD, United States of America.
  • Division of Biostatistics and Bioinformatics, Department of Public Health and Epidemiology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.

ORCID-Profile: Olusegun A Adeyemi, Jaih Craddock, Trevor A Crowell

Förderung

  • CDC HHS
  • NIMH NIH HHS
  • FIC NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • U.S. Department of Defense
  • Centers for Disease Control and Prevention

Zitieren

APA

Adeyemi, O. A., Nowak, R. G., Marzinke, M., Morgan, D., Sam-Agudu, N., Craddock, J., Zhan, M., Crowell, T. A., Baral, S., Ndembi, N., Adebajo, S., Charurat, M. E., & TRUST/RV368 Study Group (2023). Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in Nigeria. PLOS ONE. https://doi.org/10.1371/journal.pone.0282999

Vancouver

Adeyemi OA, Nowak RG, Marzinke M, Morgan D, Sam-Agudu N, Craddock J, et al. Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in Nigeria. PLOS ONE. 2023. doi:10.1371/journal.pone.0282999

BibTeX
@article{Adeyemi2023,
  author = {Adeyemi, Olusegun A and Nowak, Rebecca G and Marzinke, Mark and Morgan, Daniel and Sam-Agudu, Nadia and Craddock, Jaih and Zhan, Min and Crowell, Trevor A and Baral, Stefan and Ndembi, Nicaise and Adebajo, Sylvia and Charurat, Manhattan E and TRUST/RV368 Study Group, TRUST/RV368 Study Group},
  title = {Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in Nigeria},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0282999}
}
Kostenlos starten →